Study population and lifestyle habits evaluation
Out of the 135 eligible free-living older adults aged ≥ 65 volunteers, only 66 (21 M/45 F; mean age±SD: 70,6±4,5 years) accepted to participate in the trial and were randomized as follows: 34 to the Camelina group and 32 to the placebo group. A total of 50 subjects completed the study, 14 dropped out because of Covid-19 containment measures, but they did not differ as to the collected data from those remaining in the study, therefore a per protocol analysis was adopted. The CONSORT (Consolidated Standards of Reporting Trials) flowchart for the study is presented in Figure CONSORT (Consolidated Standards of Reporting Trials) flowchart for the studyTable General characteristics and description of lifestyle parameters of participants included in the study (n = 66) at T0BMI, Body mass index; WC, waist circumference; EF, epicardial fat; MET, metabolic equivalent of task; M, male; F, female; SD, standard deviation; N, number; %, percentage; Data were reported as mean ± SD, number (N) and percentage (%). T-test comparing mean values and Chi-square test comparing frequencies in placebo and Camelina groups.Concerning dietary and lifestyle habits, no significant differences in physical activity levels and smoking habits were observed at T0. On the contrary, the placebo group showed significantly healthier eating habits than the Camelina one (59.5±6.77 vs. 55.6±6.51; p=0,032) (Table 